The third issue of Legalease's zappy little bimonthly Life Sciences, Law & Business has now been published. It contains, among other things, the following features:
* "IP Valuation -- Evaluation in Phamaceutical Projects" by PricewaterhouseCoopers' Lucinda Spicer and Jo Pisani (or should that be LucindaspicerandJopisani?);
* "Multi-party Actions -- Who Pays the Costs?" by Anna McKay (Roiter Zucker);
* "Global Healthcare -- TRIPs and Access to Medicines" by veteran patent expert Philip Grubb (Novartis International).
The IPKat says "enjoy".
Monday, 13 September 2004
Posted by Jeremy at 3:06:00 p.m.